UNBELIEVABLE: Elixir - The Untold Story

Best guitar strings for every musician: A comprehensive guide

Whether you’re a beginner or a blues guitarist, strap your guitar with the best strings to enhance your sound and maintain quality over time

Evening Standard · Mar 6, 2025

“Exceeds in playability, looks, and affordability”: Cort promises the pinnacle of affordable acoustic guitars with its $449 Essence series

Grand Auditorium and OM Cutaway models feature in the all-new vintage-modern electric-acoustic designs

Guitar World · Feb 12, 2025

Rite Aid's Elixir Sale Receives Court Approval, Boosts Finances!

Rite Aid's bankruptcy woes take an elixir-infused turn as they secure court approval for a 5 million sale, bringing hope to their uncertain future.

Top News · Jan 9, 2024

Brand new Glasgow burger joint set to open from the team behind Elixir

A completely new restaurant is coming to Glasgow, offering sliders and shakes - from the people who brought us Elixir earlier in the year.

Glasgow Live · Sep 4, 2022

Pernod Ricard to sell Tormore brand and distillery to Elixir

Latest deal follows the sale of The Whisky Exchange to the drinks group last year

Insider UK · Jun 22, 2022

New Glasgow shisha lounge and restaurant Elixir to serve wagyu beef burgers

Elixir will open next week serving burgers 'like they've never been done before', near Bridge Street subway station, with the owner saying it will be a one-stop-shop with a premium offering.

Glasgow Live · Apr 28, 2022

Is Rite Aid Stock a Buy After Reporting Strong Q4 Results?

Leading pharmaceutical retailer Rite Aid (RAD) shares jumped last week thanks to its stronger-than-expected fourth-quarter revenue growth driven by an increase in same-store and pharmacy sales. Although the company’s strategic initiatives to boost membership should bode well for the stock, its struggling Elixir business and expanding losses could lead to…

StockNews.com · Apr 18, 2022

Why Rite Aid Shares Are Soaring Today

Rite Aid Corp (NYSE:RAD) has reported Q4 FY22 sales of 6.06 billion, +2.5% Y/Y, beating the consensus of $5.95 billion. The Company reported an EPS loss of $(1.63) compared to $(0.78) a year ago. The growth is driven by growth in the Retail Pharmacy, partially offset by a decline in the Pharmacy…

Benzinga · Apr 14, 2022